The Strategic Nuance of Contract Research Expenses in the Maryland Research and Development Tax Credit

Contract research expenses represent sixty-five percent of the costs paid to third parties for performing qualified research on a taxpayer’s behalf, provided the taxpayer retains economic risk and substantial rights to the results. In Maryland, these expenses only qualify for the state’s Research and Development Tax Credit if the underlying research activities are physically conducted within the borders of the state. 1

The Maryland Research and Development (R&D) Tax Credit program serves as a cornerstone of the state’s economic strategy to foster innovation, particularly in the biotechnology, manufacturing, and information technology sectors. 4 By allowing businesses to offset a portion of their qualifying research expenditures against their state income tax liability, Maryland incentivizes both established corporations and emerging startups to keep their intellectual property development local. 3 Central to this program is the concept of Maryland Qualified Research and Development Expenses (MQRDE), which mirrors the federal definition found in Section 41(b) of the Internal Revenue Code (IRC) but adds a critical geographic restriction: the activities must be performed in Maryland. 6 Within the MQRDE framework, contract research expenses (CRE) often represent a significant portion of a firm’s R&D budget, especially for small businesses that lack the internal infrastructure to perform specialized laboratory or engineering tasks. 9

The Legal Framework of Contract Research Expenses

The foundation of the Maryland R&D credit is built upon Tax-General Article § 10-721, which explicitly adopts the definitions of “qualified research” and “qualified research expenses” as set forth in the federal IRC. 8 Specifically, Maryland law defines MQRDE as qualified research expenses under § 41(b) of the IRC that are incurred for research conducted in the state. 11 This alignment with federal standards ensures that the complexity of defining what constitutes “research” is largely offloaded to the IRS and federal treasury regulations, while the Maryland Department of Commerce and the Comptroller focus on the local application and geographic sourcing of those costs. 7

Under IRC § 41(b)(3), contract research expenses are defined as sixty-five percent of any amount paid or incurred by the taxpayer to any person (other than an employee) for the performance of qualified research. 1 This haircut is intended to account for the overhead and profit margins typically built into third-party contracts, ensuring that the tax credit only subsidizes the actual research component of the payment. 14 For payments made to certain qualified research consortia, the percentage increases to seventy-five percent, and for basic research payments to universities or non-profits, the entire one hundred percent may be eligible under certain conditions. 4

The Three-Part Test for Contract Research Eligibility

For a payment to qualify as a contract research expense under the rigorous standards of the Maryland Comptroller and the IRS, it must satisfy a three-part test derived from Treasury Regulation § 1.41-2(e). 2 These requirements ensure that the taxpayer is truly the one driving the innovation and bearing the financial consequences of the project’s success or failure. 16

Prior Agreement Requirement

The first requirement is that the agreement between the taxpayer and the contractor must be entered into prior to the performance of the research. 2 This prevents taxpayers from retroactively reclassifying standard service or procurement contracts as “research contracts” after the fact. While the regulation does not strictly require a written contract, the Maryland Department of Commerce strongly advises maintaining formal documentation to survive an audit. 2

Performance on Behalf of the Taxpayer

The second requirement is that the research must be performed “on behalf of” the taxpayer. 2 This means the taxpayer must have substantial rights to the research results. If the contractor retains the exclusive right to use the results of the research or if the taxpayer is merely purchasing a finished product without gaining rights to the underlying technology, the expense will likely be disqualified. 16 In the context of Maryland’s high-tech corridor, this often arises in collaborative agreements between private firms and university laboratories. 4

The Economic Risk Doctrine

The third and most contentious requirement is that the taxpayer must bear the “economic risk” of the research. 2 The agreement must require the taxpayer to pay the contractor regardless of whether the research is successful. 2 If the contract is structured as a “contingent fee” where payment is only due if a specific result is achieved, the IRS and the Maryland Comptroller view the contractor as the one performing the research for their own benefit, and the taxpayer is merely a purchaser of a successful outcome. 16 This “failed research” test is a primary focus during state audits of R&D claims. 14

Contract Type Economic Risk Maryland R&D Credit Eligibility
Fixed-Price (Paid regardless of success) Taxpayer Eligible (65% of cost)
Time and Materials Taxpayer Eligible (65% of cost)
Success-Based / Contingent Fee Contractor Ineligible
Purchase of Off-the-Shelf Software N/A (Procurement) Ineligible

2

Geographic Sourcing and Maryland Guidance

While federal rules define what an expense is, Maryland’s unique contribution to the regulatory landscape is determining where that expense is “incurred.” 11 The Maryland Department of Commerce and the Comptroller have joint authority to adopt regulations specifying the standards for research conducted in the state. 8 According to Tax-General § 10-721(f)(2), these regulations must consider the location where services are performed, the residence or business location of the personnel performing those services, and the location where supplies are consumed. 8

For contract research, this creates a significant compliance hurdle. A Maryland-based company that hires a contractor in Virginia to perform laboratory testing cannot claim those expenses for the Maryland R&D tax credit, even though those same expenses would be eligible for the federal credit. 3 The burden of proof lies with the taxpayer to demonstrate that the contractor’s personnel were physically located in Maryland while performing the work. 9

Comptroller Technical Guidance and Application

The Maryland Comptroller’s office provides administrative releases that clarify the interaction between state credits and federal law. Administrative Release No. 42 and others emphasize that the Maryland credit is a “certified” credit, meaning it must be approved by the Department of Commerce before it can be claimed on a tax return. 18 For contract research, the application instructions for Form 500CR require the business to confirm that all eligible Maryland qualified R&D expenses, including those involving third-party vendors, were incurred in Maryland. 9

Furthermore, the state prevents “double-dipping” by prohibiting a taxpayer from claiming a credit for expenses paid to a third-party vendor if that vendor is also claiming a credit for those same expenses. 9 This is particularly relevant in the subcontracting world. A prime contractor and a subcontractor cannot both claim the same dollar spent on research; the entity that bears the economic risk and owns the substantial rights (the prime contractor, in a properly structured agreement) is typically the one entitled to the credit. 9

Calculating the Maryland R&D Credit

Maryland uses an incremental calculation method that is significantly more generous for “growth” than for “basic” spending, though recent legislative changes have simplified the landscape. 6 Traditionally, the state offered two distinct credits: the Basic R&D Credit and the Growth R&D Credit. 6 However, following Senate Bill 196 (Acts of 2021), the program was altered to eliminate the basic credit for many filers and shift focus toward the 10% Growth Credit. 19

The Maryland Base Amount Formula

The Maryland Base Amount is the product of the “fixed-base percentage” and the average annual Maryland gross receipts for the four preceding taxable years. 4 The fixed-base percentage is calculated as follows:

$$\text{Fixed-Base \%} = \frac{\sum \text{Maryland QREs for 4 preceding years}}{\sum \text{Maryland Gross Receipts for 4 preceding years}}$$

4

If a business has not been in existence for four years, the calculation is performed using the years available. 11 For startups or firms in their first year of claiming the credit, the fixed-base percentage is effectively zero, allowing them to claim the full 10% credit on their initial research expenditures. 4

Proration and Statutory Caps

Unlike the federal R&D credit, which is an uncapped entitlement for any taxpayer that meets the criteria, the Maryland R&D credit is subject to a strict annual funding cap. 7 Currently, the total amount of credits approved by the Department of Commerce cannot exceed $12 million per year. 7 This pool is divided into two “buckets”:

  1. $8.5 million for large businesses (those with assets of $5 million or more). 4
  2. $3.5 million for small businesses (those with net book value assets of less than $5 million). 4

If the total amount of credits applied for in either bucket exceeds the available funds, the Department must prorate the awards. 4 For example, if large businesses apply for $17 million in credits, each applicant would only receive 50% of the credit they calculated on their application. 4 There is also a firm-specific cap: no single applicant can receive more than $250,000 in credits in a single year after proration. 4

Small Business Benefits and Refundability

Maryland provides a critical advantage to small businesses that distinguishes its program from many other states. 4 For a business with net book value assets of less than $5 million at the beginning or end of the tax year, the R&D tax credit is fully refundable. 3 This means that if a small biotech startup has $100,000 in certified R&D credits but zero tax liability because it is not yet profitable, the state will issue a check for the full $100,000. 4

Determining Small Business Status

To qualify as a “small business,” the entity must provide proof of its asset value, typically via a balance sheet included in its federal tax return. 4 The “net book value” is defined as total assets (including intangibles) minus depreciation and amortization, without deducting liabilities. 4

Business Type Asset Threshold Refundability Allocation Pool
Small Business < $5 Million Fully Refundable $3.5 Million
Large Business $\ge$ $5 Million Carryforward Only (7 years) $8.5 Million

4

Application and Compliance Timeline

The administrative process for the Maryland R&D credit is rigid and requires careful planning. 3 Because the state needs to calculate proration across all applicants, the credit cannot be claimed on an original return filed in April for the preceding year. 13 Instead, there is a multi-step “look-back” process. 4

  1. Incur Expenses: The business pays for qualified research (including contract research) during the tax year (e.g., 2024).
  2. Submit Application: By November 15 of the following year (2025), the business must submit an application to the Maryland Department of Commerce detailing its expenses and gross receipts. 5
  3. Receive Certification: By February 15 of the next year (2026), the Department issues a certification letter stating the approved credit amount after proration. 5
  4. Claim the Credit: The business then files an amended Maryland tax return for the year the expenses were incurred (the 2024 return) or attaches the certificate to a future return. 8 Unused credits for large businesses can be carried forward for up to seven years. 4

Failure to meet the November 15 deadline is fatal to the claim; there is no provision for late filing or “reasonable cause” extensions for the application itself. 4

The “One Big Beautiful Bill” (OBBBA) and Its Implications

The tax landscape for R&D underwent a dramatic shift with the federal passage of the “One Big Beautiful Bill Act” (OBBBA) on July 4, 2025. 26 This legislation primarily addressed the treatment of R&D expenditures under IRC Section 174, which had previously been forced into a mandatory five-year amortization schedule by the Tax Cuts and Jobs Act (TCJA) of 2017. 27

The OBBBA restored the ability for businesses to immediately deduct (“expense”) one hundred percent of their domestic R&D costs in the year they are incurred. 27 For Maryland taxpayers, this creates both opportunities and complexities. 30 Maryland law generally conforms to the IRC, but it has a “trigger” mechanism: if a federal amendment impacts state revenue by more than $5 million, it is not automatically adopted and requires express legislative action. 32

Retroactive Relief for Small Businesses

A key provision of the OBBBA allows small businesses (defined for this purpose as those with average annual gross receipts of $31 million or less) to retroactively expense R&D costs from the 2022, 2023, and 2024 tax years. 26 This is achieved by filing amended returns or taking a “catch-up” deduction on the 2025 return. 26

For contract research expenses, this is a major liquidity event. Companies that were previously forced to amortize 65% of their contractor payments over five years can now potentially claw back those deductions all at once. 27 However, businesses must be careful to distinguish between Section 174 “research and experimental” expenditures (the deduction) and Section 41 “qualified research expenses” (the credit). 15 While they are related, the OBBBA change only applies to the deduction, though it indirectly affects the R&D credit by changing the tax liability that the credit offsets. 28

Provision Pre-OBBBA (TCJA) Post-OBBBA (2025)
Domestic R&D Deduction 5-Year Amortization 100% Immediate Expensing
Foreign R&D Deduction 15-Year Amortization 15-Year Amortization (Unchanged)
Small Biz Retroactivity None Available for 2022-2024
Sec. 179 Expensing Limit $1.25 Million $2.5 Million

27

Detailed Example: Contract Research in a Biotech Scenario

To illustrate the practical application of these rules, consider “Chesapeake Bio-Labs,” a Maryland-based biotechnology startup. In 2024, the company had $2,000,000 in net book value assets and zero gross receipts. To develop a new enzyme-based diagnostic tool, they performed the following:

  1. In-House Wages: $200,000 for Maryland-based scientists.
  2. Supplies: $50,000 in lab materials used in Baltimore.
  3. Contractor A (Maryland): Paid $300,000 to a specialized lab in Frederick, MD to perform DNA sequencing. The contract states the lab must be paid regardless of results, and Chesapeake Bio-Labs owns the data.
  4. Contractor B (Virginia): Paid $100,000 to a lab in Arlington, VA to conduct a separate toxicity study.

Step 1: Identify Maryland Qualified Research Expenses (MQRDE)

  • Wages: $200,000 (100% eligible).
  • Supplies: $50,000 (100% eligible).
  • Contractor A: $300,000 $\times$ 65% = $195,000. (Eligible because work was performed in MD).
  • Contractor B: $0. (Ineligible for the Maryland credit because work was performed outside the state).

Total MQRDE = $445,000. 1

Step 2: Calculate Initial Credit

Since Chesapeake Bio-Labs is a startup with no prior R&D spending, its Maryland Base Amount is zero. 4

Initial Credit = 10% of $445,000 = $44,500. 7

Step 3: Apply Proration and Certification

Chesapeake Bio-Labs applies for the $44,500 credit by November 15, 2025. 7 Assuming the small business pool ($3.5M) is oversubscribed and only 80% of requested credits are funded, the Department of Commerce certifies a credit of:

$44,500 $\times$ 0.80 = $35,600. 4

Step 4: Refund Claim

In February 2026, Chesapeake Bio-Labs receives its certificate. Because its assets are under $5 million, it files an amended 2024 Maryland return and requests a refund check for $35,600, regardless of whether it owed any state taxes. 4

Audit Defense and Documentation Requirements

The Maryland Comptroller has become increasingly sophisticated in auditing R&D claims, often mirroring the IRS “Audit Techniques Guide” for research credits. 2 For contract research expenses, the auditor’s primary goal is to ensure that the 65% rule is applied correctly and that the work was truly performed in Maryland. 2

Essential Records for Contract Research

To successfully defend a CRE claim, a taxpayer should maintain a “project file” for each contractor that includes:

  • The Master Service Agreement (MSA) and Statements of Work (SOW): These must be dated before work began and clearly state that the taxpayer retains rights to the IP and bears the economic risk (i.e., no contingent fees). 2
  • Invoices: These should be itemized. If an invoice includes both research and non-research items (like administrative fees or equipment rentals), only the research portion is eligible for the 65% calculation. 2
  • Proof of Performance in Maryland: This is the most frequently missed document. Taxpayers should request a written statement from the contractor certifying the location of the lab or office where the work was performed and the residency of the key personnel involved. 9
  • Deliverables: Laboratory notebooks, technical reports, and white papers provided by the contractor serve as evidence that qualified research actually occurred. 10

The “Substantially All” Rule and Indirect Costs

It is important to note that while 65% of the total payment is the statutory “qualified expense,” the underlying services provided by the contractor must themselves be “qualified services.” 2 If a contractor is hired to perform both R&D and general administrative work, only the R&D portion of the invoice should be subjected to the 65% rule. 2

Additionally, Section 41 requires that “substantially all” (interpreted as 80% or more) of the research activities for each business component constitute a process of experimentation. 1 If a contractor’s work is primarily routine testing or data entry without a process of evaluating alternatives to solve technical uncertainty, the entire contract may be disqualified. 1

Maryland Revenue Office Guidance and Judicial Precedent

The Maryland Comptroller and the Department of Commerce provide a suite of guidance documents, including formal regulations and administrative releases. Regulation 03.04.10.02 provides the procedural roadmap for firms claiming the credit, emphasizing that “all members of the same controlled group of corporations… shall be treated as a single taxpayer.” 12 This prevents companies from spinning off R&D departments into separate legal entities just to qualify for the small business refund or to manipulate the base amount calculation. 6

Administrative Release No. 42 and Reciprocity

While Administrative Release No. 42 primarily focuses on credits for taxes paid to other states, it underscores the Comptroller’s focus on “source of income.” 18 In the R&D context, this aligns with the requirement that the “benefit” of the credit (the innovation) is sourced to Maryland. 3 If a company claims an R&D credit in Maryland while simultaneously claiming a credit in another state for the same contractor’s work, the Maryland Comptroller will likely flag the return for a residency and sourcing audit. 18

The Role of the Tax Court

Maryland’s Tax Court has historically supported the Comptroller’s strict adherence to documentation requirements. 15 In cases involving digital advertising or information technology services—where the line between “service” and “research” is often blurred—the court looks for evidence of “technical uncertainty.” 10 If a contractor is simply coding to a known specification without a “trial-and-error” process, the Tax Court has consistently upheld the denial of the credit. 1

Trends and Statistical Outlook

Data from the Maryland Department of Commerce and legislative evaluations indicate that the R&D credit is one of the most popular and “oversubscribed” incentives in the state. 3 The $12 million cap is routinely reached, leading to proration for both small and large businesses. 4

Industry Distribution

The “Information” and “Professional, Scientific, and Technical Services” sectors typically receive the lion’s share of credits. 35 Within the Information sector, roughly 87% of awards go to firms involved in social media, data processing, computer infrastructure, and software publishing. 35 This highlights the growing importance of “software as a business component” in R&D claims, where contract research often involves hiring third-party developers for custom algorithmic work. 35

Metric 2024/2025 Program Year Estimate
Total Program Cap $12,000,000
Small Business Set-Aside $3,500,000
Average Proration Rate (Est.) 35% – 45% of requested credits
Max Award per Firm $250,000
Total Recipients (Est.) 600 – 700 businesses

7

Recent Legislative Alterations

The Maryland General Assembly has shown a commitment to extending the program, with the current sunset date set for June 30, 2027. 7 However, the 2025 legislative session saw the introduction of HB 35, which proposed an “Income Tax Benefit Transfer Program.” 24 This would allow technology companies with unused R&D credits (i.e., large companies that have more credits than they can use in seven years) to sell or transfer those credits to other Maryland taxpayers. 24 While the bill has strict limits ($15M lifetime cap per company), it signals a potential shift toward making the credit even more liquid for the tech sector. 24

Advanced Compliance Strategies for Contract Research

To maximize the value of the Maryland R&D tax credit, businesses must go beyond simple accounting and engage in proactive contract management. The following strategies are recommended for firms heavily reliant on third-party contractors:

Mandatory In-State Certification Clauses

Every R&D contract involving Maryland-based work should include a clause requiring the contractor to provide an annual “Certificate of Maryland Performance.” This document should state the specific address of the facility used for the research and confirm that the personnel assigned to the project are residents or primary workers in the state. 9 This preemptively addresses the primary documentation hurdle during a state audit.

Separating R&D from Procurement

Auditors frequently disqualify “contract research” that is buried within larger manufacturing or procurement agreements. To avoid this, firms should issue separate Statements of Work (SOWs) for the research phase of a project vs. the production phase. 2 If a contractor is developing a prototype and then manufacturing 1,000 units, only the prototype development costs are eligible for the 65% credit. 10 Clearly separating these costs on the invoice prevents the “contamination” of research expenses with non-qualified manufacturing costs.

Monitoring the “Small Business” Asset Threshold

Because the refundability of the credit hinges on the $5 million asset threshold, firms nearing this limit must carefully manage their balance sheets. 4 Since the test is performed at “the beginning or end of the taxable year,” an unexpected capital infusion or equipment purchase late in the year could push a firm over the limit and turn a refundable check into a carryforward-only credit. 4 Tax planning should involve a mid-year asset review to determine the most likely filing status.

Future Outlook: Digital Services and the Expanding R&D Definition

As the economy shifts toward digital products, the definition of “research” is expanding. Maryland’s recent implementation of a 3% sales tax on data and IT services (effective July 1, 2025) adds another layer of complexity. 37 While certain R&D contracts involving university partners remain exempt from this sales tax, most commercial R&D contracts may now be subject to it. 37 Firms must ensure that the 3% sales tax paid on contractor invoices is accounted for correctly in their R&D credit calculations; while the tax itself is an expense, it is generally considered an “indirect” cost and may not be eligible for the 65% credit under federal regulations. 2

Furthermore, the “One Big Beautiful Bill” Act’s impact on state revenue will continue to be a topic of debate in Annapolis. If Maryland decouples from the federal expensing rules to preserve its fiscal solvency, firms will face a “compliance gap” where they expense costs for federal purposes but amortize them for state purposes. 32 This would require maintaining two sets of R&D books, increasing the administrative burden on taxpayers. 29

Conclusion

The inclusion of contract research expenses in the Maryland R&D tax credit offers a vital financial bridge for companies seeking to leverage external expertise without sacrificing their state tax benefits. However, the path to a successful claim is paved with rigorous federal definitions and strict state-level geographic requirements. For a taxpayer to prevail, they must not only prove the technical merit of the research under the four-part test but also demonstrate a mastery of the “economic risk” and “substantial rights” doctrines that govern third-party arrangements.

The recent passage of the OBBBA at the federal level has introduced a new era of immediate expensing, providing significant cash flow opportunities for small businesses through retroactive claims. For Maryland-based firms, this federal windfall must be balanced against the state’s idiosyncratic certification process and the ever-present reality of proration. As the state continues to refine its definitions of “in-state” activities—particularly in the face of a burgeoning digital and remote-work economy—the strategic documentation of contractor locations and contract structures will remain the single most important factor in securing and defending these valuable tax assets. Businesses that proactively align their legal agreements with these tax requirements will find themselves best positioned to capture the full 10% growth incentive and, for small enterprises, the critical lifeline of a fully refundable credit. 3


Are you eligible?

R&D Tax Credit Eligibility AI Tool

Why choose us?

directive for LBI taxpayers

Pass an Audit?

directive for LBI taxpayers

What is the R&D Tax Credit?

The Research & Experimentation Tax Credit (or R&D Tax Credit), is a general business tax credit under Internal Revenue Code section 41 for companies that incur research and development (R&D) costs in the United States. The credits are a tax incentive for performing qualified research in the United States, resulting in a credit to a tax return. For the first three years of R&D claims, 6% of the total qualified research expenses (QRE) form the gross credit. In the 4th year of claims and beyond, a base amount is calculated, and an adjusted expense line is multiplied times 14%. Click here to learn more.

Never miss a deadline again

directive for LBI taxpayers

Stay up to date on IRS processes

Discover R&D in your industry

R&D Tax Credit Preparation Services

Swanson Reed is one of the only companies in the United States to exclusively focus on R&D tax credit preparation. Swanson Reed provides state and federal R&D tax credit preparation and audit services to all 50 states.

If you have any questions or need further assistance, please call or email our CEO, Damian Smyth on (800) 986-4725.
Feel free to book a quick teleconference with one of our national R&D tax credit specialists at a time that is convenient for you.

R&D Tax Credit Audit Advisory Services

creditARMOR is a sophisticated R&D tax credit insurance and AI-driven risk management platform. It mitigates audit exposure by covering defense expenses, including CPA, tax attorney, and specialist consultant fees—delivering robust, compliant support for R&D credit claims. Click here for more information about R&D tax credit management and implementation.

Our Fees

Swanson Reed offers R&D tax credit preparation and audit services at our hourly rates of between $195 – $395 per hour. We are also able offer fixed fees and success fees in special circumstances. Learn more at https://www.swansonreed.com/about-us/research-tax-credit-consulting/our-fees/

R&D Tax Credit Training for CPAs

directive for LBI taxpayers

Upcoming Webinars

R&D Tax Credit Training for CFPs

bigstock Image of two young businessmen 521093561 300x200

Upcoming Webinars

R&D Tax Credit Training for SMBs

water tech

Upcoming Webinars

Choose your state

find-us-map